Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & working
1.2.1 Data collection
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Metabolism assays industry 3600 synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product type trends
2.5 Application trends
2.6 Technology trend
2.7 End-use trends
Chapter 3 Metabolism Assays Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rise in prevalence of chronic diseases
3.2.1.2 Increasing R&D expenditure
3.2.1.3 Technological advancements
3.2.1.4 Growing demand for personalized medicines
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of metabolism assay analyzers
3.2.2.2 Presence of alternative methods and techniques
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By application
3.3.3 By technology
3.3.4 By end-use
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technology landscape
3.7 Future market trends
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis, 2023
4.3 Company market share analysis, 2023
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis
4.6 Strategy dashboard, 2023
Chapter 5 Metabolism Assays Market Size and Forecast, By Product Type, 2018-2032 (USD Million)
5.1 Key product type trends
5.2 Assay kits & reagents
5.3 Instruments & analyzers
Chapter 6 Metabolism Assays Market Size and Forecast, By Application, 2018-2032 (USD Million)
6.1 Key application trends
6.2 Diagnostics
6.2.1 Diabetes
6.2.2 Obesity
6.2.3 Cancer
6.2.4 Cardiovascular diseases
6.2.5 Other diagnostic applications
6.3 Research
Chapter 7 Metabolism Assays Market Size and Forecast, By Technology, 2018-2032 (USD Million)
7.1 Key technology trends
7.2 Colorimetry
7.3 Fluorimetry
7.4 Spectrometry
Chapter 8 Metabolism Assays Market Size and Forecast, By End-use, 2018-2032 (USD Million)
8.1 Key end-use trends
8.2 Hospitals
8.3 Diagnostic laboratories
8.4 Pharmaceutical & biopharmaceutical companies
8.5 Other end-users
Chapter 9 Metabolism Assays Market Size and Forecast, By Region, 2018-2032 (USD Million)
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of MEA
Chapter 10 Company Profiles
10.1 Merck KGaA
10.2 Thermo Fisher Scientific, Inc.
10.3 Abcam Plc
10.4 Agilent Technologies, Inc.
10.5 Promega Corporation
10.6 Kaneka Eurogentec S.A (Kaneka Corporation)
10.7 RayBiotech Life, Inc.
10.8 Sartorius AG
10.9 Elab Science Biotechnology Inc.
10.10 BMG Labtech
10.11 Biotrend Chemikalien GmbH
